Hildrox 25 Tablet contains Hydroxyzine 25 mg, an antihistamine with anxiolytic, sedative, and antiemetic properties. It is primarily indicated for the management of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Hydroxyzine acts by antagonizing central and peripheral histamine H1 receptors, thereby reducing allergic symptoms such as pruritus and urticaria. Additionally, it exhibits significant sedative effects, making it useful in preoperative sedation and in the treatment of nausea and vomiting. Hildrox 25 is also employed in the symptomatic relief of allergic conditions including chronic urticaria and atopic dermatitis. The recommended dosage varies depending on the indication, patient age, and clinical response, with careful titration advised to minimize adverse effects. Common side effects include drowsiness, dry mouth, and headache, while caution is warranted in patients with a history of cardiac arrhythmias or prolonged QT interval. Hydroxyzine should be used under medical supervision, particularly in elderly patients and those with hepatic or renal impairment. It is contraindicated in individuals with hypersensitivity to hydroxyzine or related compounds. Hildrox 25 offers effective symptomatic relief through its multifaceted pharmacological actions.